Figure 2
Figure 2. SC-EPOCH-RR drug doses and schedule. SC-EPOCH-RR is administered through a central line. Patients have a complete blood count twice weekly and at least 3 days apart. Cyclophosphamide is reduced 25% for a nadir absolute neutrophil count (ANC) less than 0.5 × 109/L (500/mm3) or platelet count less than 25.0 × 109/L (25 000/mm3) lasting 2 to 4 days and 50% if the nadir ANC was less than 0.5 × 109/L (500/mm3) or platelet count less than 25.0 × 109/L (25 000/mm3) lasting for 5 or more days, based on twice weekly blood counts.

SC-EPOCH-RR drug doses and schedule. SC-EPOCH-RR is administered through a central line. Patients have a complete blood count twice weekly and at least 3 days apart. Cyclophosphamide is reduced 25% for a nadir absolute neutrophil count (ANC) less than 0.5 × 109/L (500/mm3) or platelet count less than 25.0 × 109/L (25 000/mm3) lasting 2 to 4 days and 50% if the nadir ANC was less than 0.5 × 109/L (500/mm3) or platelet count less than 25.0 × 109/L (25 000/mm3) lasting for 5 or more days, based on twice weekly blood counts.

Close Modal

or Create an Account

Close Modal
Close Modal